Journal of Clinical Immunology

, Volume 1, Issue 3, pp 141–148 | Cite as

Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans

  • Gabriel Fernandes
  • Sudhir Gupta
Original Articles
Accepted:

Abstract

Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) were examined in the peripheral blood lymphocytes and their major subpopulations from young and aging subjects. Monocyte-depleted unseparated lymphocyte-mediated NK activity (against cells of K-562) and ADCC (against IgG-coated chicken erythrocytes) were comparable between young and aging subjects. Similarly no significant difference was observed in T cell-mediated NK and ADCC and non-T cell-mediated ADCC between young and aging subjects. Non-T cell-mediated NK activity, however, was significantly (P<0.025) greater in aging humans compared to that of young subjects. When the data were analyzed according to gender, T cell-mediated ADCC in aging males was significantly (P<0.05) greater than that found in young males. No significant difference was observed between T-cell ADCC among young and aging females. T cell-mediated NK was comparable among young and aging males and young and aging females. Non-T cell-mediated NK as well as ADCC activity was significantly (P<0.025 or <0.05) greater in aging males compared to that in young males. Both non-T-cell NK and ADCC were comparable among young and aging females. This study demonstrates an increase in NK and ADCC activity in aging subjects that is primarily shared by males and not by females. No correlation was observed between the proportion of Tγ cells and T-cell NK or ADCC activity.

Key words

Natural killer cells antibody-dependent cytotoxicity aging lymphocyte subpopulations 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kay MMB, Makinodan T: Immunobiology of aging: Evaluation of current status. Clin Immunol Immunopathol 6:394–413, 1976Google Scholar
  2. 2.
    Makinodan T, Perkins EH, Chen MG: Immunological activity of the aged. Adv Gerontol Res 3:171–198, 1971Google Scholar
  3. 3.
    Goodman SA, Makinodan T: Effect of age on cell-mediated immunity in long lived mice. Clin Exp Immunol 19:533–542, 1975Google Scholar
  4. 4.
    Mathies M, Lipps L, Smith GS, Walford RL: Age-related decline in response to phytohemagglutinin and pokeweed mitogen by spleen cells from hamster and long lived mouse strain. J Gerontol 28:425–430, 1973Google Scholar
  5. 5.
    Krohn PL: Transplantation and aging.In Topics in Biology of Aging, PL Krohn (ed). New York, Interscience, 1966, pp 125–173Google Scholar
  6. 6.
    Rodey GE, Good RA, Yunis EJ: Progressive lossin vitro of cellular immunity with aging in strain of mice susceptible to autoimmune disease. Clin Exp Immunol 9:305–311, 1971Google Scholar
  7. 7.
    Segre D, Segre M: Humoral immunity in aged mice. II. increased suppressor T cell activity in immunologically deficient old mice. J Immuol 116:735–738, 1976Google Scholar
  8. 8.
    Schulof RS, Garofalo JA, Good RA, Gupta S: Concanavalin A-induced suppressor cell activity for T cell proliferative responses: Autologous and allogeneic suppression in aging humans. Cell Immunol 56:80–88, 1980Google Scholar
  9. 9.
    Barrett DJ, Stenmark S, Wara DW, Ammann AJ: Immuno-regulation in aged humans. Clin Immunol Immunopathol 17:203–211, 1980Google Scholar
  10. 10.
    Antel JP, Weinrich M, Arnason BG: Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol 9:134–141, 1978Google Scholar
  11. 11.
    Reisen W, Keller H, Skvaril F, Morell A, Baranden S: Restriction of immunoglobulin heterogeneity, autoimmunity and serum protein levels in aged people. Clin Exp Immunol 26:280–285, 1976Google Scholar
  12. 12.
    Valtuena JR, Gonzalez-Guilabert MI, Del Pozo-Parez MA, Del Pozo-Crespo F, Velsco-Alonso R: Autoimmunity, immunoglobulins and T lymphocyte population in old age. Biomedicine 19:301–303, 1973Google Scholar
  13. 13.
    Fudenberg HH: Genetically determined immune deficiency as the predisposing cause of “autoimmunity” and lymphoid neoplasia. Am J Med 51:295–298, 1971Google Scholar
  14. 14.
    Toh BH, Roberts-Thomson IC, Mathews JD, Whittingham S, Mackay IR: Depression of cell-mediated immunity in old age and the immunopathic diseases, systemic lupus erythematosus, chronic hepatitis and rheumatoid arthritis. Clin Exp Immunol 14:193–202, 1973Google Scholar
  15. 15.
    Hallgren HM, Buckley CE, Gilbertsen VA, Yunis EJ: Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J Immunol 111:1101–1107, 1973Google Scholar
  16. 16.
    Gupta S, Fernandes F, Nair M, Good RA: Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations. Proc Natl Acad Sci 75:5137–5141, 1978Google Scholar
  17. 17.
    Kall MA, Koren HS: Heterogeneity of human natural killer cell populations. Cell Immunol 40:58–68, 1978Google Scholar
  18. 18.
    Pichler WJ, Gendelman FW, Nelson DL: Fc receptors on human T lymphocytes. II. Cytotoxic capabilities of human Tγ and Tε, B and L cells. Cell Immunol 42:410–417, 1978Google Scholar
  19. 19.
    Moretta L, Mingari MC, Romanzi CA: Loss of Fc receptors for IgG from human T lymphocytes exposed to IgG immune complexes. Nature 272:618–620, 1978Google Scholar
  20. 20.
    Wisloff R, Froland SS, Michaelson TE: Antibody-dependent cytotoxicity mediated by human Fc receptor bearing cells lacking markers for B and T lymphocytes. Int Arch Allergy Appl Immunol 47:139–154, 1974Google Scholar
  21. 21.
    Caraux J, Thierry C, Serrou B: Quantitative comparison of K cell potential in human T and null cells. Eur J Immunol 8:806–812, 1978Google Scholar
  22. 22.
    Shen L, Lydyard PM, Penfold P, Roitt IM: Evidence for antibody-dependent cell-mediated cytotoxicity by T cells bearing receptors for IgG. Clin Exp Immunol 35:276–285, 1979Google Scholar
  23. 23.
    Sandilands G, Gray K, Cooney A, Froebel K, Anderson JR: Human lymphocyte subpopulations and K cells. Int Arch Allergy Appl Immunol 50:416–426, 1976Google Scholar
  24. 24.
    West WH, Cannon GB, Kay HD, Bonnard GD, Herberman RB: Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line. Characterization of effector cells. J Immunol 118:255–361, 1977Google Scholar
  25. 25.
    Pross HF, Jondal M: Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol 21:226–235, 1975Google Scholar
  26. 26.
    Gupta S, Good RA: Subpopulations of human T lymphocytes. X. Alterations in T, B, third population cells, and T cells with receptors for immunoglobulin M (Tε) of G (Tγ) in aging humans. J Immunol 122:1214–1219Google Scholar
  27. 27.
    Kiessling R, Haller O: Natural killer cells in the mouse: An alternative immune surveillance mechanism. Contemp Top Immunobiol 8:171–201, 1978Google Scholar
  28. 28.
    Herberman RB, Holden HT: Natural cell-mediated cytotoxicity. Adv Cancer Res 28:305–377, 1978Google Scholar
  29. 29.
    Gupta S: Natural killer cells. Immunologists fancy? Gastroenterology 78:865–867, 1980Google Scholar
  30. 30.
    Gupta S, Good RA: Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids and irradiation. Cell Immunol 34:10–18, 1977Google Scholar
  31. 31.
    Fernandes G, Yunis EJ, Good RA: Age and genetic influence on immunity in NZB and autoimmune resistant mice. Clin Immunol Immunopathol 6:318–333, 1976Google Scholar
  32. 32.
    Weksler ME, Hutteroth TM: Impaired lymphocyte function in aged humans. J Clin Invest 53:99–104, 1974Google Scholar
  33. 33.
    Pisciotta AV, Westring D, DePrey C, Walsh B: Mitogenic effect of phytohemagglutins at different ages. Nature 215:193–194, 1967Google Scholar
  34. 34.
    Hefton JM, Darlington GJ, Casazza BA, Weksler ME: Immunologic studies of aging. V. Impaired proliferation of PHA responsive human lymphocytes in culture. J Immunol 125:1007–1010, 1980Google Scholar
  35. 35.
    Hallgren HM, Yunis EJ: Suppressor lymphocytes in young and aged humans. J Immunol 118:2004–2008, 1977Google Scholar
  36. 36.
    Rowley MJ, Buchanan H, Mackay IR: Reciprocal change with age in antibody to extrinsic and intrinsic antigens. Lancet 2:24–26, 1968Google Scholar
  37. 37.
    Roberts-Thomson IC, Whittingham S, Youngchaiynd N, Mackay IR: Aging, immune response and mortality. Lancet 2:368–370, 1974Google Scholar
  38. 38.
    Axelson U, Bachman R, Hallen J: Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 179:234, 1966Google Scholar
  39. 39.
    Kasai M, Laclerc JC, McVay-Boudreau L, Shen W, Cantor H: Direct evidence that natural killer cells in non-immune spleen cell populations prevent tumor growthin vivo. J Exp Med 149:1260–1264, 1979Google Scholar
  40. 40.
    Ault KA, Weiner HL: Natural killing of measles-infected cells by human lymphocytes. J Immunol 122:2611–2616, 1979Google Scholar
  41. 41.
    Harfast B, Andersson T, Perlmann P: Immunoglobulin independent natural cytotoxicity of Fc receptor-bearing human blood lymphocytes to mumps virus-infected target cells. J Immunol 121:755–761, 1978Google Scholar
  42. 42.
    Takasugi M, Mickey MR, Tarasaki PI: Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res 33:2898–2902, 1973Google Scholar
  43. 43.
    Oldham RK, Djeu JV, Cannon GB, Siwarski D, Herberman RB: Cellular microcytotoxicity in human tumor systems: Analysis of results. J Natl Cancer Inst 55:1305–1318, 1975Google Scholar
  44. 44.
    Rosenberg EB, Herberman RB, Levine PH, Halterman RH, McCoy JC, Wunderlich JR: Lymphocyte cytotoxicity reactions to leukemia associated antigens in identical twins. Int J Cancer 9:648–658, 1972Google Scholar
  45. 45.
    Rosenberg EB, McCoy JC, Green SS, Donnelly FC, Siwarski DF, Levine PH, Herberman RB: Destruction of human lymphoid tissue culture cell lines by human peripheral lymphocytes in51Cr release cellular cytotoxicity assays. J Natl Cancer Inst 52:345–352, 1974Google Scholar
  46. 46.
    Lopez C, Kirkpatrick D, Sorell M, O'Reilly RJ, Chang C: Association between pretransplant natural killer and graft versus host disease following stem cell transplantation. Lancet 11:1103–1105, 1979Google Scholar
  47. 47.
    Nagel J, Adler WH: Immune function in human aging population.In Immunological Aspects of Aging, D Segre, L Smith (eds). New York, American Elsevier (in press)Google Scholar
  48. 48.
    Herberman RB, Nunn ME, Larvin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16:216–229, 1975Google Scholar
  49. 49.
    Keissling R, Klein E, Wigzell H: Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5:112–117, 1975Google Scholar
  50. 50.
    Datta SK, Gallagher MT, Trentin JJ: Natural cell-mediated cytotoxicity in hamsters. Int J Cancer 23:728–734, 1979Google Scholar
  51. 51.
    McConnchie PR, Rachlefsky G, Stiehm ER, Terasaki PI: Antibody-dependent lymphocyte killer function and age. Pediatrics 52:795–800, 1973Google Scholar
  52. 52.
    de Landazuri MO, Silva A, Alvarez J, Herberman RB: Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations. J Immunol 123:252–258, 1979Google Scholar
  53. 53.
    Jensen PA, Koren HS: Depletion of NK by cellular immunoadsorption. J Immunol 123:1127–1132, 1979Google Scholar
  54. 54.
    Herberman RB, Nunn ME, Holden HT, Larvin DH: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 16:230–239, 1975Google Scholar
  55. 55.
    Kiessling R, Tetranyi G, Karre K, Jondal M, Tracey D, Wigzell H: Killer cells: A functional comparison between natural immune T cell and antibody-dependentin vitro systems. J Exp Med 143:772–780, 1976Google Scholar
  56. 56.
    Platsoucas CD, Fernandes G, Gupta SL, Kempin S, Clarkson B, Good RA, Gupta S: Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia. Augmentation byin vitro treatment with interferon. J Immunol 125:1216–1223, 1980Google Scholar
  57. 57.
    Zarling JM, Eskra L, Borden EC, Horoszewicz J, Carter WA: Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon. J Immunol 123:63–70, 1979Google Scholar
  58. 58.
    Santoni A, Riccardi C, Barlozzari T, Herberman RB: Inhibition as well as augmentation of mouse NK activity by pyrancopolymer and adriamycin.In Natural Cell-Mediated Immunity against Tumors, RB Herberman (ed). New York, Academic Press, 1980, pp 753–764Google Scholar
  59. 59.
    Tracey DE: The requirement for macrophages in the augmentation of natural killer cell activity by BCG. J Immunol 123:840–845, 1979Google Scholar
  60. 60.
    Ortaldo JR, Phillips W, Wasserman K, Herberman RS: Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity. J Immunol 125:1839–1844, 1980Google Scholar
  61. 61.
    Cudkowicz G, Hochman PS: Regulation of natural killer activity by macrophage-like and other types of suppressor cells.In Developmental Immunobiology, GW Siskind, ME Weksler, SD Litwin (eds). New York, Grune & Stratton, 1978, pp 1–21Google Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • Gabriel Fernandes
    • 1
  • Sudhir Gupta
    • 1
  1. 1.Memorial Sloan-Kettering Cancer CenterNew York

Personalised recommendations